Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases.
Friedegund Elke Meier
No relevant relationships to disclose
Andrea Forschner
No relevant relationships to disclose
Bernhard Klumpp
No relevant relationships to disclose
Keith T. Flaherty
No relevant relationships to disclose
Juergen Bernd Honegger
No relevant relationships to disclose
Maria Witte
No relevant relationships to disclose
Antje Bornemann
No relevant relationships to disclose
Reinhard Dummer
No relevant relationships to disclose
Juergen Bauer
No relevant relationships to disclose
Ghazaleh Tabatabai
No relevant relationships to disclose
Benjamin Weide
No relevant relationships to disclose
Thomas K. Eigentler
No relevant relationships to disclose
Dirk Schadendorf
No relevant relationships to disclose
Leticia Quintanilla-Fend
No relevant relationships to disclose
Heike Niessner
No relevant relationships to disclose
Claus Garbe
No relevant relationships to disclose